Immune Design Corp.
IMDZ
IMDZ was delisted on the 1st of April, 2019.
28 hedge funds and large institutions have $63.5M invested in Immune Design Corp. in 2014 Q3 according to their latest regulatory filings, with 28 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.4M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$10.1M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$9.37M |
| 4 |
JP Morgan Chase
New York
|
+$3.44M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$2.53M |
Top Sellers
IMDZ Hedge Fund Activity: Q3 2014 in Review
28 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q3 2014, worth a combined $63.5M.
Buyers outnumbered sellers: 28 funds opened new IMDZ positions and 0 closed out — a net gain of 28 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $11.4M.
- 28 institutional investors held Immune Design Corp. (IMDZ) as of Q3 2014, up from 0 in Q2 2014.
- Funds reported $63.5M of Immune Design Corp. stock for Q3 2014.
- 28 funds opened new Immune Design Corp. positions in Q3 2014 and 0 closed out, a net change of +28 holders.
- The largest Immune Design Corp. buyer in Q3 2014 was Fidelity Investments, an estimated $11.4M added.
Based on aggregated 13F filings for Q3 2014.